Skip to main content
Erschienen in: Breast Cancer Research 6/2013

01.12.2013 | Viewpoint

Refining the role of BRCA1 in combating oxidative stress

verfasst von: Jeffrey R Marks

Erschienen in: Breast Cancer Research | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

The BRCA1 hereditary susceptibility gene has been studied in great depth, befitting its clear role in promoting basal type breast cancer and serous type ovarian (fallopian tube) cancer in women carrying germline mutations. The BRCA1 protein has long been implicated in maintaining genome integrity through DNA repair processes. However, a number of studies have demonstrated that BRCA1 is also involved in the response to oxidative stress. A recent paper by Gorrini and colleagues extends our mechanistic understanding of how BRCA1 regulates this pathway. The relative contribution of this activity in BRCA1-associated tumorigenesis and DNA damage response remains unknown.
Literatur
1.
Zurück zum Zitat Lakhani SR, Manek S, Penault-Llorca F, Flanagan A, Arnout L, Merrett S, McGuffog L, Steele D, Devilee P, Klijn JG, Meijers-Heijboer H, Radice P, Pilotti S, Nevanlinna H, Butzow R, Sobol H, Jacquemier J, Lyonet DS, Neuhausen SL, Weber B, Wagner T, Winqvist R, Bignon YJ, Monti F, Schmitt F, Lenoir G, Seitz S, Hamman U, Pharoah P, Lane G, et al: Pathology of ovarian cancers in BRCA1 and BRCA2 carriers. Clin Cancer Res. 2004, 10: 2473-2481. 10.1158/1078-0432.CCR-1029-3.CrossRefPubMed Lakhani SR, Manek S, Penault-Llorca F, Flanagan A, Arnout L, Merrett S, McGuffog L, Steele D, Devilee P, Klijn JG, Meijers-Heijboer H, Radice P, Pilotti S, Nevanlinna H, Butzow R, Sobol H, Jacquemier J, Lyonet DS, Neuhausen SL, Weber B, Wagner T, Winqvist R, Bignon YJ, Monti F, Schmitt F, Lenoir G, Seitz S, Hamman U, Pharoah P, Lane G, et al: Pathology of ovarian cancers in BRCA1 and BRCA2 carriers. Clin Cancer Res. 2004, 10: 2473-2481. 10.1158/1078-0432.CCR-1029-3.CrossRefPubMed
2.
Zurück zum Zitat Lee E, McKean-Cowdin R, Ma H, Spicer DV, Van Den Berg D, Bernstein L, Ursin G: Characteristics of triple-negative breast cancer in patients with a BRCA1 mutation: results from a population-based study of young women. J Clin Oncol. 2011, 29: 4373-4380. 10.1200/JCO.2010.33.6446.CrossRefPubMedPubMedCentral Lee E, McKean-Cowdin R, Ma H, Spicer DV, Van Den Berg D, Bernstein L, Ursin G: Characteristics of triple-negative breast cancer in patients with a BRCA1 mutation: results from a population-based study of young women. J Clin Oncol. 2011, 29: 4373-4380. 10.1200/JCO.2010.33.6446.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Johnson N, Johnson SF, Yao W, Li YC, Choi YE, Bernhardy AJ, Wang Y, Capelletti M, Sarosiek KA, Moreau LA, Chowdhury D, Wickramanayake A, Harrell MI, Liu JF, D'Andrea AD, Miron A, Swisher EM, Shapiro GI: Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance. Proc Natl Acad Sci U S A. 2013, 110: 17041-17046. 10.1073/pnas.1305170110.CrossRefPubMedPubMedCentral Johnson N, Johnson SF, Yao W, Li YC, Choi YE, Bernhardy AJ, Wang Y, Capelletti M, Sarosiek KA, Moreau LA, Chowdhury D, Wickramanayake A, Harrell MI, Liu JF, D'Andrea AD, Miron A, Swisher EM, Shapiro GI: Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance. Proc Natl Acad Sci U S A. 2013, 110: 17041-17046. 10.1073/pnas.1305170110.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Nguyen T, Nioi P, Pickett CB: The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem. 2009, 284: 13291-13295. 10.1074/jbc.R900010200.CrossRefPubMedPubMedCentral Nguyen T, Nioi P, Pickett CB: The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem. 2009, 284: 13291-13295. 10.1074/jbc.R900010200.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Shibata T, Ohta T, Tong KI, Kokubu A, Odogawa R, Tsuta K, Asamura H, Yamamoto M, Hirohashi S: Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proc Natl Acad Sci U S A. 2008, 105: 13568-13573. 10.1073/pnas.0806268105.CrossRefPubMedPubMedCentral Shibata T, Ohta T, Tong KI, Kokubu A, Odogawa R, Tsuta K, Asamura H, Yamamoto M, Hirohashi S: Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proc Natl Acad Sci U S A. 2008, 105: 13568-13573. 10.1073/pnas.0806268105.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Bae I, Fan S, Meng Q, Rih JK, Kim HJ, Kang HJ, Xu J, Goldberg ID, Jaiswal AK, Rosen EM: BRCA1 induces antioxidant gene expression and resistance to oxidative stress. Cancer Res. 2004, 64: 7893-7909. 10.1158/0008-5472.CAN-04-1119.CrossRefPubMed Bae I, Fan S, Meng Q, Rih JK, Kim HJ, Kang HJ, Xu J, Goldberg ID, Jaiswal AK, Rosen EM: BRCA1 induces antioxidant gene expression and resistance to oxidative stress. Cancer Res. 2004, 64: 7893-7909. 10.1158/0008-5472.CAN-04-1119.CrossRefPubMed
7.
Zurück zum Zitat Gorrini C, Baniasadi PS, Harris IS, Silvester J, Inoue S, Snow B, Joshi PA, Wakeham A, Molyneux SD, Martin B, Bouwman P, Cescon DW, Elia AJ, Winterton-Perks Z, Cruickshank J, Brenner D, Tseng A, Musgrave M, Berman HK, Khokha R, Jonkers J, Mak TW, Gauthier ML: BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival. J Exp Med. 2013, 210: 1529-1544. 10.1084/jem.20121337.CrossRefPubMedPubMedCentral Gorrini C, Baniasadi PS, Harris IS, Silvester J, Inoue S, Snow B, Joshi PA, Wakeham A, Molyneux SD, Martin B, Bouwman P, Cescon DW, Elia AJ, Winterton-Perks Z, Cruickshank J, Brenner D, Tseng A, Musgrave M, Berman HK, Khokha R, Jonkers J, Mak TW, Gauthier ML: BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival. J Exp Med. 2013, 210: 1529-1544. 10.1084/jem.20121337.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Saha T, Rih JK, Rosen EM: BRCA1 down-regulates cellular levels of reactive oxygen species. FEBS Lett. 2009, 583: 1535-1543. 10.1016/j.febslet.2009.04.005.CrossRefPubMedPubMedCentral Saha T, Rih JK, Rosen EM: BRCA1 down-regulates cellular levels of reactive oxygen species. FEBS Lett. 2009, 583: 1535-1543. 10.1016/j.febslet.2009.04.005.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Martinez-Outschoorn UE, Balliet R, Lin Z, Whitaker-Menezes D, Birbe RC, Bombonati A, Pavlides S, Lamb R, Sneddon S, Howell A, Sotgia F, Lisanti MP: BRCA1 mutations drive oxidative stress and glycolysis in the tumor microenvironment: implications for breast cancer prevention with antioxidant therapies. Cell Cycle. 2012, 11: 4402-4413. 10.4161/cc.22776.CrossRefPubMedPubMedCentral Martinez-Outschoorn UE, Balliet R, Lin Z, Whitaker-Menezes D, Birbe RC, Bombonati A, Pavlides S, Lamb R, Sneddon S, Howell A, Sotgia F, Lisanti MP: BRCA1 mutations drive oxidative stress and glycolysis in the tumor microenvironment: implications for breast cancer prevention with antioxidant therapies. Cell Cycle. 2012, 11: 4402-4413. 10.4161/cc.22776.CrossRefPubMedPubMedCentral
10.
11.
Zurück zum Zitat Ma J, Cai H, Wu T, Sobhian B, Huo Y, Alcivar A, Mehta M, Cheung KL, Ganesan S, Kong AN, Zhang DD, Xia B: PALB2 interacts with KEAP1 to promote NRF2 nuclear accumulation and function. Mol Cell Biol. 2012, 32: 1506-1517. 10.1128/MCB.06271-11.CrossRefPubMedPubMedCentral Ma J, Cai H, Wu T, Sobhian B, Huo Y, Alcivar A, Mehta M, Cheung KL, Ganesan S, Kong AN, Zhang DD, Xia B: PALB2 interacts with KEAP1 to promote NRF2 nuclear accumulation and function. Mol Cell Biol. 2012, 32: 1506-1517. 10.1128/MCB.06271-11.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat De Lorenzo SB, Patel AG, Hurley RM, Kaufmann SH: The elephant and the blind men: making sense of PARP inhibitors in homologous recombination deficient tumor cells. Front Oncol. 2013, 3: 228-CrossRefPubMedPubMedCentral De Lorenzo SB, Patel AG, Hurley RM, Kaufmann SH: The elephant and the blind men: making sense of PARP inhibitors in homologous recombination deficient tumor cells. Front Oncol. 2013, 3: 228-CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Woods NT, Mesquita RD, Sweet M, Carvalho MA, Li X, Liu Y, Nguyen H, Thomas CE, Iversen ES, Marsillac S, Karchin R, Koomen J, Monteiro AN: Charting the landscape of tandem BRCT domain-mediated protein interactions. Sci Signal. 2012, 5: rs6-CrossRefPubMedPubMedCentral Woods NT, Mesquita RD, Sweet M, Carvalho MA, Li X, Liu Y, Nguyen H, Thomas CE, Iversen ES, Marsillac S, Karchin R, Koomen J, Monteiro AN: Charting the landscape of tandem BRCT domain-mediated protein interactions. Sci Signal. 2012, 5: rs6-CrossRefPubMedPubMedCentral
Metadaten
Titel
Refining the role of BRCA1 in combating oxidative stress
verfasst von
Jeffrey R Marks
Publikationsdatum
01.12.2013
Verlag
BioMed Central
Erschienen in
Breast Cancer Research / Ausgabe 6/2013
Elektronische ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr3583

Weitere Artikel der Ausgabe 6/2013

Breast Cancer Research 6/2013 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.